Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E-cigarettes for Smoking Reduction in Schizophrenia
NCT02918630Completed
- Sponsor
- UTHealth Houston
- Start
- Oct 2016
- Primary completion
- Aug 2017
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of nicotine patch in Tobacco Use Disorder (TUD) (2 arms), sponsored by UTHealth Houston. Primary endpoints: Change in Smoking as Assessed by Breath Carbon Monoxide Levels at Week 5, Change in Smoking as Assessed by Urinary Cotinine Levels at Week 5 and 1 more. Started Oct 2016; status: completed.
02
Drugs
nicotine patch
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02918630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02918630.